Ceruloplasmin, Human Plasma recombinant protein
Ferroxidase
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
| Primary Accession | P00450 |
|---|---|
| Calculated MW | 132.0 kDa |
| Gene ID | 1356 |
|---|---|
| Gene Symbol | CP |
| Other Names | Ferroxidase |
| Gene Source | Human |
| Source | Human plasma |
| Assay&Purity | SDS-PAGE; ≥95% |
| Assay2&Purity2 | HPLC; |
| Recombinant | No |
| Target/Specificity | Ceruloplasmin |
| Application Notes | Reconstitute in deionized H₂O. Aliquot and store at –20°C. Avoid freeze-thaw cycles. |
| Format | Lyophilized protein |
| Storage | -20°C; Lyophilized from 50 mM potassium phosphate, pH 6.8, 100 mM KCl and 20 mM €-amino caproic acid + 5 mM EDTA. |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
An acute-phase reactant. Increased levels are associated with normal pregnancy, rheumatoid arthritis, and cirrhosis. Decreased levels are associated with hepatolenticular degeneration (Wilson's Disease). An elevated level of Cp is found in patients with progressive tumors. Additionally, as Cp is a pro-oxidant, an elevated level is a sign of cardiovascular disease.
References
Koschinsky M.L.,et al.Proc. Natl. Acad. Sci. U.S.A. 83:5086-5090(1986).
Daimon M.,et al.Biochem. Biophys. Res. Commun. 208:1028-1035(1995).
Mercer J.F.B.,et al.FEBS Lett. 203:185-190(1986).
Bingle C.D.,et al.Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
Yang F.,et al.Proc. Natl. Acad. Sci. U.S.A. 83:3257-3261(1986).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.





Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.

